Dishman June quarter net climbs 14 per cent to Rs 46 crore
Net sales, however, declined to Rs 365.9 crore during the June quarter as against Rs 400 crore a year earlier, Dishman Pharmaceuticals said in a regulatory filing.
By PTI | Updated:
NEW DELHI: Dishman Pharmaceuticals and Chemicals today posted a 13.7 per cent rise in consolidated net profit at Rs 45.5 crore for the quarter ended June.
The company had reported a net profit of Rs 40.02 crore in the same period of 2015-16.
Net sales, however, declined to Rs 365.9 crore during the June quarter as against Rs 400 crore a year earlier, Dishman Pharmaceuticals said in a regulatory filing.
The stock today ended at Rs 164.75 on BSE, down 1.58 per cent from its previous close.
The company had reported a net profit of Rs 40.02 crore in the same period of 2015-16.
Net sales, however, declined to Rs 365.9 crore during the June quarter as against Rs 400 crore a year earlier, Dishman Pharmaceuticals said in a regulatory filing.
The stock today ended at Rs 164.75 on BSE, down 1.58 per cent from its previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Dishman Carbogen Amcis opens $50 million new facility in FranceADVERTISEMENT
